|
Re: Clinical Trial LCC0418 Phase II
I am not on this therapy but I'm actually a PhD in Immunology and stage IV breast cancer warrior myself- and can say that it is great that you are enrolling in this therapy. I've studied dendritic cells in my research and I know for a fact that this therapy has a lot of potential. It would be a great break through if it can help in breast cancer, I will pray that those little dendritic cells get fully primed against those nasty cancer antigens and then they go on to kill the cells in your body.
As a former researcher myself (I left science to spend time home with my family), it brings me such joy to know that there are people like you out there to help test and prove that immunotherapy is a valuable tool in the fight against cancer.
Huggs!
__________________
[B]Kristin
Aug 2010: diagnosed stage 3b, 4 mo. after birth of son. 29 yrs old and breastfeeding, ER/PR-, Her-2+ started Neoadjuvant therapy: 4x FEC, 10x abraxane & Herceptin
Feb 2011: L mx with recon. Path. showed only DCIS but 4/10+ nodes.
March 2011: 6 wks rads.
Mother passed, lower back pain.
Late May 2011: Bone mets but organs clear; Tykerb, Xeloda, Xgeva. Stopped Herceptin. Implant infected: removed implant.
October 2011: Bone progression; Gemzar and Carboplatin & restarted Herceptin.
Jan 2012: Progression, re-classified as ER+; Tykerb, Herceptin, Zoladex & Femara. Anti-E is working!
May 2012: ovaries out, markers stable but elevated. Cont. Herceptin, Tykerb, Xgeva & Femara.
Dec 2012: aromasin
Jan 2013: faslodex, herceptin, tykerb
Jun: Kadcyla
Aug: Rads to hip, then Perjeta, Herceptin & Taxotere
Nov 2013: Perjeta, Herceptin, Halaven
Early 2014: Affinitor, Aromasin, Perjeta, Herceptin.
June 2014: Estradiol, Perjeta, Herceptin
Aug 14: Tamoxofin, H & P
http://kristin-notdying-blog.blogspot.com/
|
Threaded Mode